Back
Harvard Bioscience 10K Form
Sell
43
HBIO
Harvard Bioscience
Last Price:
2.37
Seasonality Move:
6.31%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | HBIO/Harvard Bioscience Quarterly |
| 2023-11-07 | 10Q | HBIO/Harvard Bioscience Quarterly |
| 2023-08-08 | 10Q | HBIO/Harvard Bioscience Quarterly |
| 2023-04-26 | 10Q | HBIO/Harvard Bioscience Quarterly |
| 2022-11-09 | 10Q | HBIO/Harvard Bioscience Quarterly |
| 2022-08-04 | 10Q | HBIO/Harvard Bioscience Quarterly |
Receive HBIO News And Ratings
See the #1 stock for the next 7 days that we like better than HBIO
HBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $112.25M |
|---|---|
| Cash Flow: | $-1.81M |
| Price / Cash Flow: | 16.73 |
| Annual Sales: | $1.54 |
| Price / Book: | 1.53 |
Profitability
| EPS (TTM): | -0.25000 |
|---|---|
| Net Income (TTM): | $-10.68M |
| Gross Margin: | $66.07M |
| Return on Equity: | -14.88% |
| Return on Assets: | -7.83% |
Harvard Bioscience Earnings Forecast
Key Harvard Bioscience Financial Ratios
- The Gross Profit Margin over the past 26 years for HBIO is 58.86%.
- The Selling, General & Administrative Expenses for HBIO have been equal to 41.77% of Gross Profit Margin.
- The Research & Development expenses have been 10.48% of Revenue.
- The Interest Expense is -105.15% of Operating Income.
- The Net Earning history of HBIO is -3.04% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 13 years.
Harvard Bioscience Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | HBIO |
| CUSIP: | 416906 |
| Website: | harvardbioscience.com |
Debt
| Debt-to-Equity Ratio: | 0.53 |
|---|---|
| Current Ratio: | 2.05 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 15.73 |
HBIO Technical Analysis vs Fundamental Analysis
Sell
43
Harvard Bioscience (HBIO)
is a Sell
Is Harvard Bioscience a Buy or a Sell?
-
Harvard Bioscience stock is rated a Sell
The current Harvard Bioscience [HBIO] share price is $2.36. The Score for HBIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.